Tissue World Magazine
Alexandra Stuthridge, Technical Business Manager, BioProducts Institute (BPI)

Metsä Tissue has completed a €55m investment at its Krapkowic paper mill. The investment includes two new, state-of-the-art tissue paper machines, a new AfH product converting line as well as extending its converting and warehousing to new facilities.

The investment increases the mill’s tissue production capacity up to 85,000tpy and converting capacity up to 50,00tpy.

Kari Jordan, president and chief executive, Metsä Group, said: “The renewed Krapkowice mill is the most modern tissue facility in Europe. “This investment is strategically important to Metsä Group as it strengthens our market position and competitiveness in the Polish tissue market. “Today’s consumers want sustainably manufactured, high-quality hygiene products. Our Polish mill meets these expectations extremely well.”

The company is “seeking strong growth” in Poland and nearby markets where “the demand for new tissue products is increasing significantly”. It has reduced the mill’s CO2 emissions by 60%, reduced its NOx emissions by over 50% and “has virtually eliminated” SOx emissions. Due to major improvements in water usage and treatment, the amount of wastewater has also been reduced by 42%.

The Krapkowice mill produces Metsä Tissue’s top brands Lambi, Mola and Katrin for consumer and AfH markets. The mill uses both virgin and recycled fibre.